Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Vanhoecke

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Supportive and Palliative Care|April 15, 2015
Host-microbe cross talk in cancer therapyBarbara Vanhoecke, Andrea Stringer
In Vitro Cellular & Developmental Biology. Animal|February 28, 2009
Cell aggregation on agar as an indicator for cell-matrix adhesion: effects of opioidsDelphine Debruyne, Marc Mareel, Barbara Vanhoecke, et al.
Anticancer Research|April 1, 2009
Chronic lymphocytic leukaemiaJerina Boelens, Sofie Lust, Barbara Vanhoecke, et al.
Pathology Oncology Research : POR|March 29, 2019
Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat ModelDaniel Thorpe, Ross Butler, Masooma Sultani, et al.
Peerj|November 22, 2017
5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition <i>in vitro</i>Eline Vanlancker, Barbara Vanhoecke, Andrea Stringer, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 30, 2011
P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude miceKoen Jacobs, Lynn Feys, Barbara Vanhoecke, et al.
Journal of Medical Microbiology|June 15, 2016
5-Fluorouracil sensitivity varies among oral micro-organismsEline Vanlancker, Barbara Vanhoecke, Rozel Smet, et al.
Molecular Nutrition & Food Research|September 7, 2005
Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanismSofie Lust, Barbara Vanhoecke, Ann Janssens, et al.
Mutation Research|February 25, 2010
From clinical observations of intensity-modulated radiotherapy to dedicated in vitro designsStéphanie Blockhuys, Barbara Vanhoecke, Carlos De Wagter, et al.
Expert Review of Proteomics|April 3, 2012
Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsCharlotte Grootaert, Tom Van de Wiele, Willy Verstraete, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Supportive and Palliative Care|April 15, 2015
Host-microbe cross talk in cancer therapyBarbara Vanhoecke, Andrea Stringer
In Vitro Cellular & Developmental Biology. Animal|February 28, 2009
Cell aggregation on agar as an indicator for cell-matrix adhesion: effects of opioidsDelphine Debruyne, Marc Mareel, Barbara Vanhoecke, et al.
Anticancer Research|April 1, 2009
Chronic lymphocytic leukaemiaJerina Boelens, Sofie Lust, Barbara Vanhoecke, et al.
Pathology Oncology Research : POR|March 29, 2019
Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat ModelDaniel Thorpe, Ross Butler, Masooma Sultani, et al.
Peerj|November 22, 2017
5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition <i>in vitro</i>Eline Vanlancker, Barbara Vanhoecke, Andrea Stringer, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 30, 2011
P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude miceKoen Jacobs, Lynn Feys, Barbara Vanhoecke, et al.
Journal of Medical Microbiology|June 15, 2016
5-Fluorouracil sensitivity varies among oral micro-organismsEline Vanlancker, Barbara Vanhoecke, Rozel Smet, et al.
Molecular Nutrition & Food Research|September 7, 2005
Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanismSofie Lust, Barbara Vanhoecke, Ann Janssens, et al.
Mutation Research|February 25, 2010
From clinical observations of intensity-modulated radiotherapy to dedicated in vitro designsStéphanie Blockhuys, Barbara Vanhoecke, Carlos De Wagter, et al.
Expert Review of Proteomics|April 3, 2012
Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationshipsCharlotte Grootaert, Tom Van de Wiele, Willy Verstraete, et al.
Pageof 4